• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

UroMems

UroMems reports positive outcomes in first-ever female-only study of smart implant for incontinence

February 21, 2025 By Sean Whooley

UroMems announced that the entire treatment cohort in the first-of-its-kind study in female patients successfully reached its primary endpoints. Grenoble, France-based UroMems — which has its U.S. headquarters in Minneapolis — develops an implantable system called UroActive. Powered by a MyoElectroMechanical system (MEMS), UroActive goes into the urethral duct in men and bladder neck in […]

Filed Under: Clinical Trials, Health Technology, Implants, Software / IT, Urology, Women's Health Tagged With: UroMems

The top 10 urology device stories of 2024 so far

September 23, 2024 By Sean Whooley

Urology Week 2024, which closes out The Urology Foundation’s Urology Awareness Month, is a good time to highlight the innovations in this space. This week (Sept. 23-29), is an initiative of the European Association of Urology that brings together national urological societies, urology practitioners, urology nurses, patients and their families, and politicians to create awareness of urological […]

Filed Under: Artificial Intelligence (AI), Business/Financial News, Digital Health, Featured, Funding Roundup, Gynecological, Health Technology, Imaging, Implants, Machine Learning (ML), Mergers & Acquisitions, Neurological, Neuromodulation/Neurostimulation, Software / IT, Urology Tagged With: affluentmedical, Asensus Surgical, Avation Medical, Axonics, Axonics Modulation Technologies, BD, Biobot Surgical, Boston Scientific, Cosmo Intelligent Medical Devices, Cosmo Pharmaceuticals, GE Healthcare, Johnson & Johnson, Johnson & Johnson MedTech, Karl Storz, Medtronic, NeuSpera Medical, Olympus, Procept BioRobotics, Profound Medical Inc., UroMems

UroMems raises $47M Series C

June 27, 2024 By Sean Whooley

UroMems announced that it raised $47 million in a Series C financing to support clinical trials for its smart automated artificial urinary sphincter (AUS). Grenoble, France-based UroMems — which has its U.S. headquarter in Minneapolis — developed the AUS to treat stress urinary incontinence (SUI). It expects the funds to support large-scale U.S. and European […]

Filed Under: Business/Financial News, Funding Roundup, Health Technology, Implants, Men's Health, Software / IT, Urology, Women's Health Tagged With: UroMems

UroMems has positive results for first-ever female implant of smart urinary sphincter system

February 14, 2024 By Sean Whooley

UroMems announced today that it successfully met the six-month primary endpoint for the first female patient implanted with UroActive. Grenoble, France-based UroMems designed its smart UroActive implant to treat stress urinary incontinence (SUI). The company says it’s the first smart, automated artificial urinary sphincter (AUS) to treat SUI. Powered by a MyoElectroMechanical system (MEMS), UroActive […]

Filed Under: Clinical Trials, Health Technology, Implants, Urology, Women's Health Tagged With: UroMems

UroMems reports positive feasibility data for smart urology implant

December 14, 2023 By Sean Whooley

UroMems today announced that it the treatment cohort in a feasibility study of its UroActive system reached six-month primary endpoints. Grenoble, France-based UroMems designed its smart UroActive implant to treat stress urinary incontinence (SUI). The company says it’s the first smart, automated artificial urinary sphincter (AUS) to treat SUI. Powered by a MyoElectroMechanical system (MEMS), […]

Filed Under: Clinical Trials, Implants, Urology Tagged With: UroMems

UroMems completes first-in-human study enrollment for smart urinary implant

September 12, 2023 By Sean Whooley

UroMems announced today that it successfully completed enrollment in its first-in-human study of its UroActive system. Grenoble, France-based UroMems designed the UroActiv system as a smart, automated artificial urinary sphincter (AUS). It treats stress urinary incontinence (SUI). Results from the initial study should support the design and implementation of a pivotal trial in Europe and […]

Filed Under: Clinical Trials, Health Technology, Implants, Men's Health, Urology Tagged With: UroMems

Smart implant from UroMems meets primary endpoint in first-in-human study

June 9, 2023 By Sean Whooley

UroMems announced that it successfully met the primary endpoints for the initial male patient in a study of its UroActive smart implant. Grenoble, France-based UroMems develops mechatronics technology to treat stress urinary incontinence (SUI). Its SOPHIA study evaluates the UroActive smart, automated artificial urinary sphincter (AUS) in the treatment of SUI. The company plans for […]

Filed Under: Clinical Trials, Implants, Men's Health, Urology Tagged With: UroMems

UroMems picks up FDA STeP designation for smart implant that treats urinary incontinence

April 21, 2023 By Sean Whooley

UroMems announced that it received Safer Technologies Program (STeP) designation from the FDA for its UroActive smart continence therapy. STeP, a collaborative program, helps reduce the time needed to develop and obtain marketing authorization for eligible devices. FDA launched STeP in 2021, modeling the program on its breakthrough devices designation program. STeP covers devices that […]

Filed Under: Featured, Food & Drug Administration (FDA), Gynecological, Implants, Men's Health, Regulatory/Compliance, Urology, Women's Health Tagged With: FDA, UroMems

UroMems begins first-in-human study of smart implant for treating stress urinary incontinence

November 29, 2022 By Sean Whooley

UroMems announced today that it completed the first-in-human implant of its UroActive system for treating stress urinary incontinence (SUI). Grenoble, France-based UroMems designed UroActive as a smart, automated artificial urinary sphincter (AUS) investigational device. The company said in a news release that UroActive represents the first smart, automated AUS. Kicking off the clinical study marks […]

Filed Under: Clinical Trials, Implants, Men's Health, Urology Tagged With: UroMems

UroMems adds $8.3M, brings Series B round to $27.3M

April 6, 2021 By Sean Whooley

UroMems announced today that it added $8.3 million to its Series B financing round, bringing the total funds raised to $27.3 million. Grenoble, France-based UroMems’ $27.3 million (€23 million) financing round had its first tranche completed in May 2020 but added the $8.3 million (€7 million) thanks to existing investors including Hil-Invent GmbH, Financière Arbevel, […]

Filed Under: Business/Financial News, Funding Roundup, Gynecological, Men's Health, Urology, Women's Health Tagged With: UroMems

UroMems raises $17.6m

May 20, 2020 By Sean Whooley

Electronic artificial urinary sphincter (eAUS) maker UroMems announced today that it raised $17.6 million (€16 million) in an equity and debt financing. Grenoble, France-based UroMems intends to use the proceeds from the funding to support ongoing preclinical studies and the initiation of the first clinical studies of its eAUS device for treating stress urinary incontinence […]

Filed Under: Business/Financial News, Funding Roundup, Men's Health, Urology Tagged With: UroMems

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy